These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 16468954)
21. Utility of peritransplant and rescue intravenous immunoglobulin and extracorporeal immunoadsorption in lung transplant recipients sensitized to HLA antigens. Appel JZ; Hartwig MG; Davis RD; Reinsmoen NL Hum Immunol; 2005 Apr; 66(4):378-86. PubMed ID: 15866701 [TBL] [Abstract][Full Text] [Related]
22. Phenotypic and Transcriptomic Lymphocytes Changes in Allograft Recipients After Intravenous Immunoglobulin Therapy in Kidney Transplant Recipients. Pilon C; Bigot J; Grondin C; Thiolat A; Lang P; Cohen JL; Grimbert P; Matignon M Front Immunol; 2020; 11():34. PubMed ID: 32038663 [TBL] [Abstract][Full Text] [Related]
23. Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients. Jordan SC; Toyoda M; Kahwaji J; Vo AA Am J Transplant; 2011 Feb; 11(2):196-202. PubMed ID: 21219579 [TBL] [Abstract][Full Text] [Related]
27. Clinical applications of intravenous immunoglobulins (IVIg)--beyond immunodeficiencies and neurology. Hartung HP; Mouthon L; Ahmed R; Jordan S; Laupland KB; Jolles S Clin Exp Immunol; 2009 Dec; 158 Suppl 1(Suppl 1):23-33. PubMed ID: 19883421 [TBL] [Abstract][Full Text] [Related]
28. Early Versus Late Acute Antibody-Mediated Rejection Among Renal Transplant Recipients in Terms of Response to Rituximab Therapy: A Single Center Experience. Gheith O; Al-Otaibi T; Halim MA; Mahmoud T; Nair P; Monem MA; Al-Waheeb S; Hassan R; Nampoory N Exp Clin Transplant; 2017 Feb; 15(Suppl 1):150-155. PubMed ID: 28260457 [TBL] [Abstract][Full Text] [Related]
29. Anti-HLA sensitization after kidney allograft nephrectomy: changes one year post-surgery and beneficial effect of intravenous immunoglobulin. Matignon M; Leibler C; Moranne O; Salomon L; Charron D; Lang P; Jacquelinet C; Suberbielle C; Grimbert P Clin Transplant; 2016 Jun; 30(6):731-40. PubMed ID: 27140447 [TBL] [Abstract][Full Text] [Related]
30. Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A multicenter, prospective, randomized, double-blind clinical trial. Moreso F; Crespo M; Ruiz JC; Torres A; Gutierrez-Dalmau A; Osuna A; Perelló M; Pascual J; Torres IB; Redondo-Pachón D; Rodrigo E; Lopez-Hoyos M; Seron D Am J Transplant; 2018 Apr; 18(4):927-935. PubMed ID: 28949089 [TBL] [Abstract][Full Text] [Related]
32. Immunomodulatory actions of intravenous immunoglobulin (IVIG): potential applications in solid organ transplant recipients. Jordan SC; Tyan D; Czer L; Toyoda M Pediatr Transplant; 1998 May; 2(2):92-105. PubMed ID: 10082441 [TBL] [Abstract][Full Text] [Related]
33. Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patients. Kahwaji J; Barker E; Pepkowitz S; Klapper E; Villicana R; Peng A; Chang R; Jordan SC; Vo AA Clin J Am Soc Nephrol; 2009 Dec; 4(12):1993-7. PubMed ID: 19833910 [TBL] [Abstract][Full Text] [Related]
34. Management of the highly HLA- sensitized patient. A novel role for intravenous gammaglobulin. Jordan SC Am J Transplant; 2002 Sep; 2(8):691-2. PubMed ID: 12243488 [No Abstract] [Full Text] [Related]
35. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience. Jin MK; Cho JH; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD Transplant Proc; 2012 Jan; 44(1):200-3. PubMed ID: 22310614 [TBL] [Abstract][Full Text] [Related]
36. Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization. Vo AA; Sinha A; Haas M; Choi J; Mirocha J; Kahwaji J; Peng A; Villicana R; Jordan SC Transplantation; 2015 Jul; 99(7):1423-30. PubMed ID: 25606792 [TBL] [Abstract][Full Text] [Related]
37. Safety and Efficacy of Alemtuzumab Induction in Highly Sensitized Pediatric Renal Transplant Recipients. Kim IK; Choi J; Vo AA; Kang A; Patel M; Toyoda M; Mirocha J; Kamil ES; Cohen JL; Louie S; Galera O; Jordan SC; Puliyanda DP Transplantation; 2017 Apr; 101(4):883-889. PubMed ID: 27495773 [TBL] [Abstract][Full Text] [Related]
38. Progress in Desensitization of the Highly HLA Sensitized Patient. Jordan SC; Choi J; Kahwaji J; Vo A Transplant Proc; 2016 Apr; 48(3):802-5. PubMed ID: 27234740 [TBL] [Abstract][Full Text] [Related]
39. Desensitizing the broadly human leukocyte antigen-sensitized patient awaiting deceased donor kidney transplantation. Jordan SC; Reinsmoen N; Lai CH; Cao K; Kahwaji J; Peng A; Villicana R; Vo A Transplant Proc; 2012 Jan; 44(1):60-1. PubMed ID: 22310579 [TBL] [Abstract][Full Text] [Related]